Definitive Contract IND17PC00018

<p>The U.S. Defense Advanced Research Projects Agency (DARPA) awarded a Firm Fixed Price, Definitive Contract to Probiusdx Inc., a small business, for point-of-care monitoring of the host-pathogen interaction during infection. The contract has a ceiling value of $1,746,921.00 and a period of performance ending on November 15, 2021. This contract was awarded under DARPA's SBIR (Small Business Innovation Research) Program Phase II. The place of performance is Duncans Mills, CA.</p>

This is a Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Probiusdx Inc., a small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development of point-of-care technologies to monitor and characterize host-pathogen interactions during acute severe infection. The contract has a ceiling value of $147,130.17 and an ultimate completion date of November 24, 2017. The contract is set aside for small...

<p>This is a $149,500.00 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Nanomedical Diagnostics, Inc., a small business manufacturer, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the &quot;REAL-TIME ASSESSMENT OF ANTIMICROBIAL CONCENTRATIONS FOR PERSONALIZED TREATMENT OF INFECTIOUS DISEASES.&quot; The contract was awarded on October 24, 2016 with a final completion date of July 23, 2017.</p>

The U.S. Department of Defense's Defense Advanced Research Projects Agency (DARPA) awarded a Small Business Innovation Research (SBIR) Phase I contract to Nano Terra, Inc., a self-certified small disadvantaged business, for $149,987.00. The contract is for a &quot;REAL-TIME ASSESSMENT OF ANTIMICROBIAL CONCENTRATIONS FOR PERSONALIZED TREATMENT OF INFECTIOUS DISEASES&quot;. This is a firm-fixed-price, definitive contract with a period of performance ending on November 30, 2017. The contract was...

This is a $225,000.00 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Technology Holding LLC, a small, for-profit limited liability company specializing in research and development services. The contract is part of DARPA's Small Business Innovation Research (SBIR) program and is for Phase I of an effort titled &quot;AUTONOMOUS BIOMANUFACTORING AT REMOTE LOCATIONS&quot;. The contract has a total small business set-aside and supports the development of...

This is a $999,923 Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Inflammatix, Inc., a small disadvantaged business in Sunnyvale, California. The contract is for the development of point-of-care diagnostic solutions to monitor the host-pathogen interaction during infection. Inflammatix has been awarded over $29 million in federal contracts and grants from agencies like the Department of Health and Human Services and...

This is a $794,734 firm fixed-price definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Phylagen, Inc. for the &quot;Biological Robustness in Complex Settings Program - Tracking Maritime Vessels through Microbiome Surveillance&quot; project. The contract has an ultimate completion date of September 4, 2017 and does not have a set-aside designation. The contract is focused on leveraging microbiome surveillance to track maritime vessels, which aligns with...

This is a federal contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Phylagen, Inc., a for-profit organization, for the &quot;Biological Robustness in Complex Settings (BRICS) Program&quot; related to geolocating the origin and transit history of objects through microbiome geosurveillance. The contract has a potential value of $5,057,654.00 and does not have a set-aside designation. The contract was awarded on September 29, 2017 with a completion date of December 31,...

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Xilis Inc., a for-profit manufacturing organization. The contract is for the development of tissue-derived droplet micro-organospheres as models for high-throughput testing of pathogens, with a total potential value of $224,658.00. The contract has a firm fixed price pricing type and a completion date of August 31, 2021. The original solicitation was a Broad...

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Mbio Diagnostics Inc., doing business as Lightdeck Diagnostics, for the development of a &quot;Point of Care Host-Pathogen Monitoring System.&quot; The fixed-price contract has a ceiling value of $149,503.39 and was awarded on November 18, 2016, with a completion date of November 27, 2017. Mbio Diagnostics Inc. is a for-profit organization that develops...